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Primary amyloidosis of the ureter is a rare disease that is difficult to distinguish from urothelial carcinoma. Only
50 cases of primary ureter amyloidosis have been reported since it was first described in 1937. Of these, only five
cases of ureter amyloidosis with osseous metaplasia were reported. In this study, we report the clinical pre
sentation of ureter primary amyloidosis that presented as a mass with osseous metaplasia. The aim of this study is
to provide clinicians with knowledge about the clinical/radiologic manifestation that raise the suspicion of
amyloidosis, bearing in mind the importance of differentiating it from other “malignant” processes.

1. Introduction

2. Case presentation

Primary localized amyloidosis of the ureter is a rare disease that is
clinically and radiographically difficult to distinguish from urothelial
carcinoma.1 It occurs predominantly in females.1 The mean age at
diagnosis is 58 years and most patients present with flank pain or he
maturia. The majority of ureteric involvement (up to 60% of cases) was
reported in the lower ureter, followed by the upper portion according to
a report by Ding et al.2 Only 50 cases of primary ureteric amyloidosis
have been reported since it was first described in 1937.2 Of these, only
five cases of ureter amyloidosis with osseous metaplasia were reported.
In this study, we report the clinical presentation and pathologic findings
of primary amyloidosis in the ureter and demonstrate the unusual pre
sentation of the primary amyloidosis of the ureter as a lobulated nodular
mass and pertinent osseous metaplasia association. The aim of this case
report is to provide clinicians with knowledge about the clin
ical/radiologic manifestation that raise the suspicion of amyloidosis,
bearing in mind the importance of differentiating it from other “malig
nant” processes.

We report a case of 82-year-old female with past medical history of
chronic diastolic heart failure, atrial fibrillation, and type 2 diabetes
who presented with weakness and fatigue. A computed tomography
(CT) scan of the abdomen/pelvis without contrast demonstrated an
incidental finding of right ureteral mass with layering calculi concerning
for neoplasm. The mass led to ureteral obstruction and right sided
hydronephrosis. Urine culture grew E. coli. The patient underwent ure
teroscopy with biopsy and stent placement.
Under light microscopy, the specimen revealed amorphous, ho
mogenous, eosinophilic extracellular material expanded lamina propria
and muscularis propria extending to the adventitia. Osseous metaplasia
was also apparent. Fig. 1. Congo red staining was positive with unique
apple-green birefringence on polarization. Fig. 2. Unfortunately, the
patient did not pursue further follow up.
3. Discussion
Primary localized amyloidosis in the ureter is a rare entity caused by
extracellular deposition of insoluble fibrillary protein that may result in
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as multiple myeloma. Because the clinical and radiologic findings are
non-specific, histopathologic examination of the tissue remains the gold
standard.
Amyloidosis, also named “The great imitator,” because its nonspe
cific clinical presentation.4 Although gross hematuria is a common
manifestation, clinical signs and symptoms of ureteral obstruction such
as hydronephrosis and hydroureter should raise the suspicion for
amyloidosis in the genitourinary tract. This consideration could help in
the avoidance of unnecessary surgery. Two conservative approaches can
be used to preserve renal functioning after confirming the appropriate
diagnosis by pathologic examination. One treatment option is segmental
resection of the ureter with end-to-end anastomosis, ureteral reim
plantation, and auto transplantation. The other treatment option is with
dimethyl sulfoxide (DMSO).
Microscopically, the amyloid protein deposits in the tissue as an
extracellular pale pink, homogenous, and hyaline acellular material on
hematoxylin eosin staining, mostly deposited in vascular and peri
vascular tissue.5 Congo-Red staining is generally recommended and
reveals apple-green birefringence appearance under polarized light with
high sensitivity and specificity.5 Despite the relatively straightforward
pathologic diagnosis of amyloidosis, additional subtyping is required for
guiding the treatment. This subtyping is achieved by laser microdis
section, then analysis by liquid chromatography/mass spectrometry
technology. This methodology has emerged as the preferred method of
amyloid typing and has its value for both confirmation of the diagnosis
and subtyping and characterizing the peptide composition of the amy
loidogenic protein with high sensitivity and specificity.
The differential diagnosis in this case included urothelial carcinoma,
carcinoma in situ, and atypical reactive processes. Two interesting
findings in our case were the presentation primary amyloid as a lobu
lated nodular mass formation that was suspicious for malignancy and
the apparent osseous metaplasia formation. Local resection is the rec
ommended clinical approach after ruling out a systemic disease process.

Fig. 1. H&E stains amorphic and eosinophilic acellular material in the ure
ter specimen.

4. Conclusion
Primary localized ureteral amyloidosis is a rare and benign condition
with only 50 cases reported in the literature. We report the sixth case of
localized ureteral amyloidosis with associated osseous metaplasia. Due
to the similarities in clinical/radiologic presentation with urothelial
malignancy, a high level of awareness of this entity is required by the
clinicians and pathologist to achieve an accurate diagnosis and appro
priate patient management.

Fig. 2. Positive Congo Red staining consistent with the diagnosis of ureteric
amyloidosis. (For interpretation of the references to colour in this figure legend,
the reader is referred to the Web version of this article.)

severe organ dysfunction.1 Amyloidosis is classified based on the type of
the involved amyloidogenic protein or based on tissue distribution.1
Primary amyloidosis is usually defined as amyloid immunoglobulin light
chain disease that could involve different organs typically affecting the
skin, soft tissues, genitourinary system, respiratory system, and gastro
intestinal tract. Primary amyloidosis of the genitourinary tract is rare
and most reported in the bladder and the prostate. The etiology of
localized amyloidosis is unknown. Several studies suggested that pri
mary amyloidosis could be related to chronic inflammation, monoclonal
proliferation, and local secretion of light chains. Light chains accumu
lation may transform into amyloid by lysosomal degradation.
Secondary amyloidosis is often a result of a separate disease process,
usually an underlying long term inflammatory disease such as rheu
matoid arthritis, tuberculosis, or Crohn’s disease. The kidney is the
major involved organ in the genitourinary tract.3 Alternatively, sec
ondary amyloidosis could be an indication of a neoplastic disorder such
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